Literature DB >> 11040070

Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.

A Kromminga1, C Scheckenbach, M Georgi, C Hagel, R Arndt, E Christophers, E B Bröcker, D Zillikens.   

Abstract

Bullous pemphigoid (BP) and linear IgA disease (LAD) are autoimmune subepidermal blistering skin diseases associated with autoantibodies against the transmembrane hemidesmosomal protein BP180/type XVII collagen. It has been demonstrated previously that BP is characterized predominantly by IgG autoantibodies, while autoantibodies in LAD mainly belong to the IgA isotype. The aim of the present study was to investigate the hypothesis that there is a significant overlap in the autoantibody isotype profiles associated with these two diseases. Several new recombinant forms of BP180 were generated in the baculovirus expression system, including the full-length protein. IgG autoantibodies to BP 180 were detectable in 39 of 40 (98%) of BP sera; interestingly, 88% of BP sera also contained IgA anti-BP180 autoantibodies. Similarly, anti-BP180 reactivity in LAD sera (n=22) was also attributed to both an IgA (68%) and an IgG (76%) autoantibody response. IgA and IgG autoantibodies to the intracellular portion of BP180 were found in 14% and 28% of BP sera, respectively, and in 8% of LAD sera (same percentage for both isotypes). Our findings clearly demonstrate that both BP and LAD patients have a dual IgA and IgG autoimmune response to BP180 which is directed not only to the ectodomain, but also to the intracellular portion of this protein. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040070     DOI: 10.1006/jaut.2000.0437

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  14 in total

1.  [Chronic bullous disease of childhood. Long-term therapy over 8 years with 4,4'-diaminodiphenylsulfone].

Authors:  D Pirkhammer; D Zillikens; D Födinger; P Zimmermann; K Rappersberger
Journal:  Hautarzt       Date:  2012-08       Impact factor: 0.751

Review 2.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

3.  Diagnosis and clinical severity markers of bullous pemphigoid.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  F1000 Med Rep       Date:  2009-02-24

4.  Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin.

Authors:  Cassian Sitaru; Arno Kromminga; Takashi Hashimoto; Eva B Bröcker; Detlef Zillikens
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

5.  Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

Authors:  Nina van Beek; Kristin Rentzsch; Christian Probst; Lars Komorowski; Michael Kasperkiewicz; Kai Fechner; Inga M Bloecker; Detlef Zillikens; Winfried Stöcker; Enno Schmidt
Journal:  Orphanet J Rare Dis       Date:  2012-08-09       Impact factor: 4.123

6.  Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases.

Authors:  Kinga Csorba; Sabine Schmidt; Florina Florea; Norito Ishii; Takashi Hashimoto; Michael Hertl; Sarolta Kárpáti; Leena Bruckner-Tuderman; Wataru Nishie; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2011-05-28       Impact factor: 4.123

Review 7.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

8.  Response of hemorrhagic bullous skin lesions of the breast secondary to primary systemic amyloidosis to a five-drug combination chemotherapy: a case report and review of the literature.

Authors:  Aref Agheli; Marvin Becker; Gary Becker; M Rashid Chaudhry; Jen C Wang
Journal:  Exp Hematol Oncol       Date:  2012-08-13

Review 9.  Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases.

Authors:  Zhiliang Li; Ke Jing; Suo Li; Suying Feng
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

Review 10.  Diagnosis of Autoimmune Blistering Diseases.

Authors:  Mareike Witte; Detlef Zillikens; Enno Schmidt
Journal:  Front Med (Lausanne)       Date:  2018-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.